NYMX - Nymox Pharmaceutical announces $5M registered direct offering

Nymox Pharmaceutical (NASDAQ:NYMX) entered into definitive agreements with institutional and accredited investors for the purchase and sale of ~3M shares at $1.65/share in a registered direct offering for gross proceeds of ~$5M. NYMX also agreed to issue to the investors, in a concurrent private placement, unregistered warrants to purchase up to ~3M shares. The warrants are exercisable immediately at an exercise price of $2/share and will expire 5 years from the date of an effective registration statement covering the shares underlying the warrants. The closing of the offering is expected on or about Mar. 22. NYMX intends to use the proceeds for general corporate purposes, including working capital.

For further details see:

Nymox Pharmaceutical announces $5M registered direct offering